Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Tcheng

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Coronary Artery Disease|December 22, 1999
Coronary intervention and glycoprotein IIb/IIIa integrin blockadeM Madan, J E Tcheng
The Journal of Invasive Cardiology|April 4, 2000
Platelet glycoprotein IIb/IIIa integrin inhibition in acute myocardial infarctionC O'Shea, J E Tcheng
American Heart Journal|September 29, 1999
Vale, warfarin: a stentorian farewellJ E Tcheng, D F Kong
Journal of Thrombosis and Thrombolysis|December 21, 2000
Small-molecule glycoprotein IIb/IIIa inhibitors as adjunctive therapy in percutaneous coronary interventionsJ C O'Shea, J E Tcheng
Lasers in Medical Science|August 4, 2001
Current multicentre studies with the excimer laser: design and aimsJ E Tcheng, A A Volkert-Noethen
Circulation|December 8, 1998
Glycoprotein IIb/IIIa integrin blockadeM Madan, S D Berkowitz, J E Tcheng
American Heart Journal|November 30, 1999
Hemostasis of the femoral vasculature: Shouldn't we have an answer by now?J B Pracyk, S Drennan, J E Tcheng
The Journal of Invasive Cardiology|July 4, 2001
No jacket requiredT R Gehrig, M H Sketch, J E Tcheng
Minerva Cardioangiologica|October 18, 2002
Eptifibatide in percutaneous coronary intervention. A reviewJ P Dery, J C O'Shea, J E Tcheng
Current Pharmaceutical Design|February 18, 2004
GP IIb/IIIa blockade in elective percutaneous coronary interventionJ P Dery, R A Harrington, J E Tcheng
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Coronary Artery Disease|December 22, 1999
Coronary intervention and glycoprotein IIb/IIIa integrin blockadeM Madan, J E Tcheng
The Journal of Invasive Cardiology|April 4, 2000
Platelet glycoprotein IIb/IIIa integrin inhibition in acute myocardial infarctionC O'Shea, J E Tcheng
American Heart Journal|September 29, 1999
Vale, warfarin: a stentorian farewellJ E Tcheng, D F Kong
Journal of Thrombosis and Thrombolysis|December 21, 2000
Small-molecule glycoprotein IIb/IIIa inhibitors as adjunctive therapy in percutaneous coronary interventionsJ C O'Shea, J E Tcheng
Lasers in Medical Science|August 4, 2001
Current multicentre studies with the excimer laser: design and aimsJ E Tcheng, A A Volkert-Noethen
Circulation|December 8, 1998
Glycoprotein IIb/IIIa integrin blockadeM Madan, S D Berkowitz, J E Tcheng
American Heart Journal|November 30, 1999
Hemostasis of the femoral vasculature: Shouldn't we have an answer by now?J B Pracyk, S Drennan, J E Tcheng
The Journal of Invasive Cardiology|July 4, 2001
No jacket requiredT R Gehrig, M H Sketch, J E Tcheng
Minerva Cardioangiologica|October 18, 2002
Eptifibatide in percutaneous coronary intervention. A reviewJ P Dery, J C O'Shea, J E Tcheng
Current Pharmaceutical Design|February 18, 2004
GP IIb/IIIa blockade in elective percutaneous coronary interventionJ P Dery, R A Harrington, J E Tcheng
Pageof 10